It is hotly debated that Regulations (EU) 2017/745 and 2017/746 on medical devise and in vitro diagnostic medical devices (MDR and IVDR) urgently need to be revised. Different timelines and focus points are currently discussed for the revision of the regulations.
The Council of the European Union issued a joint paper on November 28 initiated by Croatia, Finland, France, Germany, Ireland, Luxembourg, Romania, Malta and Slovenia. The paper proposes necessary reforms in the MDR and IVDR and gives its view on priorities and main points. These are:
- Reduction of administrative obligations of stakeholders
- Centralisation of system management functions to the EMA
- Foreseeable and balanced certification procedures
- Taking into account specific needs for medical devices intended for specific patient populations
- Assuring a special pathway for innovations
In the previous months, especially proposals brought forward by Parliament made the headlines. We will keep you updated about any new developments or decisions in that regard. The document can be accessed here.
Source: European Commission